Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 22 05 2020
revised: 28 08 2020
accepted: 29 09 2020
pubmed: 14 10 2020
medline: 15 12 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

The ability to identify biomarkers of psychosis risk is essential in defining effective preventive measures to potentially circumvent the transition to psychosis. Using samples of people at clinical high risk for psychosis (CHR) and Healthy controls (HC) who were administered a task fMRI paradigm, we used a framework for labelling time windows of fMRI scans as 'integrated' FC networks to provide a granular representation of functional connectivity (FC). Periods of integration were defined using the 'cartographic profile' of time windows and k-means clustering, and sub-network discovery was carried out using Network Based Statistics (NBS). There were no network differences between CHR and HC groups. Within the CHR group, using integrated FC networks, we identified a sub-network negatively associated with longitudinal changes in the severity of psychotic symptoms. This sub-network comprised brain areas implicated in bottom-up sensory processing and in integration with motor control, suggesting it may be related to the demands of the fMRI task. These data suggest that extracting integrated FC networks may be useful in the investigation of biomarkers of psychosis risk.

Identifiants

pubmed: 33048435
doi: 10.1002/hbm.25235
pmc: PMC7775992
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-451

Subventions

Organisme : Wellcome Trust
ID : 091667
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N027078/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U120097115
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202397/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : MRF
ID : MRF_C0439
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

J Abnorm Psychol. 2018 Apr;127(3):314-325
pubmed: 29672091
Cortex. 2010 Jul-Aug;46(7):831-44
pubmed: 20152963
Neuroimage. 2012 Feb 15;59(4):3548-62
pubmed: 22116037
Neuroimage. 2017 Jan 15;145(Pt B):209-217
pubmed: 27039698
Exp Brain Res. 2003 Nov;153(2):146-57
pubmed: 14610633
Neuron. 2016 Oct 19;92(2):544-554
pubmed: 27693256
Neuron. 2011 Nov 17;72(4):665-78
pubmed: 22099467
Cortex. 2018 Jan;98:203-217
pubmed: 28196647
Transl Psychiatry. 2017 May 9;7(5):e1118
pubmed: 28485725
Curr Neuropharmacol. 2012 Sep;10(3):219-30
pubmed: 23449679
Recenti Prog Med. 1989 Dec;80(12):646-52
pubmed: 2697899
Neuroimage Clin. 2014 Jul 24;5:298-308
pubmed: 25161896
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11073-8
pubmed: 17576922
Nature. 2005 Feb 24;433(7028):895-900
pubmed: 15729348
Neuroimage. 2018 Oct 15;180(Pt B):632-645
pubmed: 29038030
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7641-6
pubmed: 21502525
J Psychiatry Neurosci. 2014 Jul;39(4):239-48
pubmed: 24506946
Transl Psychiatry. 2017 Oct 3;7(10):e1245
pubmed: 28972591
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12568-12573
pubmed: 27791105
Neuroimage. 2010 Jan 1;49(1):947-55
pubmed: 19703570
Neuroimage. 2007 Aug 1;37(1):90-101
pubmed: 17560126
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11678-83
pubmed: 26324898
Neuroimage. 2010 Dec;53(4):1197-207
pubmed: 20600983
Nat Methods. 2019 Jan;16(1):111-116
pubmed: 30532080
Trends Cogn Sci. 2002 Jan 1;6(1):9-16
pubmed: 11849610
Hum Brain Mapp. 2021 Feb 1;42(2):439-451
pubmed: 33048435
Neuroimage. 2008 Sep 1;42(3):1178-84
pubmed: 18598773
Schizophr Bull. 2020 Apr 10;46(3):670-679
pubmed: 32227226
Hum Brain Mapp. 2009 Dec;30(12):4129-37
pubmed: 19530219
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Neuroimage Clin. 2020;25:102169
pubmed: 32032819
Front Psychol. 2016 Nov 25;7:1832
pubmed: 27933012
Br J Psychiatry Suppl. 2002 Sep;43:s50-7
pubmed: 12271801
Neuroimage. 2009 Jan 15;44(2):489-501
pubmed: 18835452
Brain Struct Funct. 2018 Apr;223(3):1091-1106
pubmed: 29090337
J Psychiatr Res. 2018 Aug;103:38-45
pubmed: 29772485
PLoS Comput Biol. 2015 Dec 02;11(12):e1004533
pubmed: 26629847
Neuroimage Clin. 2017 May 14;15:439-448
pubmed: 28616384
Psychiatry Res. 1989 Mar;27(3):335-50
pubmed: 2710870
Psychol Sci. 2011 Nov;22(11):1359-66
pubmed: 22006061
Schizophr Bull. 2014 Jul;40(4):904-13
pubmed: 23861539
J Vis. 2007 May 23;7(7):6.1-14
pubmed: 17685802
Neuroimage. 2015 Nov 15;122:399-407
pubmed: 26231247
Eur J Neurosci. 2005 Jul;22(1):235-46
pubmed: 16029213
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9888-91
pubmed: 27528672
JAMA Psychiatry. 2013 Nov;70(11):1143-51
pubmed: 24005188
Nat Neurosci. 2019 Aug;22(8):1371-1378
pubmed: 31285616
Neuroimage. 2016 Nov 15;142:198-210
pubmed: 27261162
Neuroimage. 2015 May 15;112:267-277
pubmed: 25770991
Neuroimage. 2012 Mar;60(1):623-32
pubmed: 22233733
Neuroimage. 2012 Jan 2;59(1):431-8
pubmed: 21810475
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Science. 2010 May 14;328(5980):876-8
pubmed: 20466926
Cereb Cortex. 1995 Mar-Apr;5(2):111-22
pubmed: 7620288
Br J Psychiatry. 2001 Jun;178:524-30
pubmed: 11388968
Arch Gen Psychiatry. 2012 Jun;69(6):562-71
pubmed: 22664547
Front Psychiatry. 2012 Dec 06;3:105
pubmed: 23230425
Cereb Cortex. 2014 Mar;24(3):663-76
pubmed: 23146964
Neuron. 2006 Aug 3;51(3):369-79
pubmed: 16880131
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13376-13381
pubmed: 30545918
Psychiatry Res. 2013 Oct 30;209(3):266-72
pubmed: 23871169

Auteurs

George Gifford (G)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Nicolas Crossley (N)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Sarah Morgan (S)

Department of Psychiatry, University of Cambridge, Cambridge, UK.
The Alan Turing Institute, London, UK.

Matthew J Kempton (MJ)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Paola Dazzan (P)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Trust, Maudsley Hospital, London, UK.

Gemma Modinos (G)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Matilda Azis (M)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Carly Samson (C)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Ilaria Bonoldi (I)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Trust, Maudsley Hospital, London, UK.

Beverly Quinn (B)

CAMEO Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.

Sophie E Smart (SE)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Mathilde Antoniades (M)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Psychiatry, Icahn Medical School, Mt Sinai Hospital, New York, New York, USA.

Matthijs G Bossong (MG)

Department of Psychiatry, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.

Matthew R Broome (MR)

Institute for Mental Health, School of Psychology, University of Birmingham, Birmingham, UK.

Jesus Perez (J)

CAMEO Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.

Oliver D Howes (OD)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Trust, Maudsley Hospital, London, UK.

James M Stone (JM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Trust, Maudsley Hospital, London, UK.
Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Paul Allen (P)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Psychology, University of Roehampton, London, UK.

Anthony A Grace (AA)

Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Philip McGuire (P)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Trust, Maudsley Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH